The Growing U.S. Hemophilia Treatment Market is driven by Rising Disease Prevalence
The U.S. hemophilia treatment market provides a diverse range of treatment options for patients. Hemophilia is a rare bleeding disorder caused due to lack or deficiency of clotting factors in blood. People affected with hemophilia either lack or have low levels of factor VIII (hemophilia A) or factor IX (hemophilia B) in their blood which prevents proper clot formation. Currently, there are...
0 Comments
0 Shares